The FDA has asked healthcare providers to identify and report any prescription drug ads and promotions that may be false or misleading.
The agency says it is launching its "Bad Ad Program" both to help clinicians "recognize misleading prescription drug promotion and provide them with an easy way to report this activity."
Providers can e-mail potential violations to badad@fda.gov or call 877-RX-DDMAC.
No comments:
Post a Comment